Hence, we prospectively examined the plasma concentrations of sMICA and TGF-β1 before and after definitive CRT, to determine whether in patients with non-metastatic HNSCC receiving definitive CRT such a correlation exists. This evidence concerns the gene TGFB1 and head and neck squamous cell carcinoma.